Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Weight matters: long-term evaluation of weight regain and fistula recurrence post endoscopic ultrasound-directed transgastric ERCP (EDGE).

Surgical endoscopy·2026

Same author

Covered Self-Expandable Metallic Stents versus Multiple Plastic Stents for Benign Biliary Strictures: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.

Avicenna journal of medicine·2026

Same author

Stress ulcer prophylaxis in mechanically ventilated patients.

The American journal of the medical sciences·2026

Same author

Endoscopic Management of Bile Leaks After Subtotal Versus Total Laparoscopic Cholecystectomy: A Single Center Comparative Analysis.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026

Same author

Agreement Between Single-Breath Derecruitment and Nitrogen Multiple-Breath Washin-Washout Methods for Estimating Functional Residual Capacity in Mechanically Ventilated Children.

Respiratory care·2026

Same author

Clinical Outcomes of Adjunctive Corticosteroid Therapy Versus Standard Treatment Alone in Patients With Bacterial Facial Infections: A Systematic Review and Meta-Analysis.

Clinical and experimental dental research·2026

Search research articles

Related Experiment Video

Updated: Jun 13, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

DeepCGAN: early Alzheimer's detection with deep convolutional generative adversarial networks.

Imad Ali¹, Nasir Saleem², Musaed Alhussein³

¹Department of Computer Science, University of Swat, Swat, KP, Pakistan.

Frontiers in Medicine

|September 13, 2024

Summary

This study introduces DeepCGAN, a novel deep learning model for early Alzheimer's disease detection. DeepCGAN achieves 97.32% accuracy, outperforming existing methods for timely diagnosis.

Keywords:

Alzheimer's disease CNN GAN cognitive features deep learning

More Related Videos

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 13, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

Area of Science:

Medical Imaging
Artificial Intelligence
Neuroscience

Background:

Alzheimer's disease (AD) is a leading cause of dementia, necessitating early detection for effective intervention.
Detecting early-stage AD via magnetic resonance imaging (MRI) is challenging due to subtle physiological differences.
Current diagnostic methods often lack the sensitivity for subtle, early-stage AD indicators.

Purpose of the Study:

To propose a Deep Convolutional Generative Adversarial Network (DeepCGAN) for enhanced early-stage Alzheimer's disease detection.
To leverage unsupervised generative models to augment limited medical imaging datasets for improved AD classification.
To improve the accuracy and robustness of early AD detection using advanced deep learning techniques.

Main Methods:

Developed a Deep Convolutional Generative Adversarial Network (DeepCGAN) employing an encoder-decoder generator and a discriminator with a similar encoder structure.
Utilized generative adversarial network (GAN) principles to expand dataset size and diversity for unsupervised learning.
Integrated a softmax classifier in the final dense layer for AD classification based on cognitive data.

Main Results:

The proposed DeepCGAN model achieved a high accuracy rate of 97.32% in detecting early-stage Alzheimer's disease.
Significantly outperformed contemporary state-of-the-art models, including Adaptive Voting, ResNet, AlexNet, GoogleNet, Deep Neural Networks, and Support Vector Machines.
Demonstrated superior performance and generalization capabilities compared to traditional and current methods.

Conclusions:

DeepCGAN enhances early AD detection accuracy and robustness through improved dataset diversity and advanced GAN techniques.
The model's high performance suggests significant potential for improving patient outcomes via timely diagnosis and intervention.
This study highlights the efficacy of DeepCGAN as a powerful tool for early Alzheimer's disease detection in medical imaging.